Literature DB >> 20609333

Five-year longitudinal treatment outcomes of the ISTAR Comprehensive Stuttering Program.

Marilyn Langevin1, Deborah Kully, Shelli Teshima, Paul Hagler, N G Narasimha Prasad.   

Abstract

UNLABELLED: Replicated evidence of satisfactory 1- and 2-year post-treatment outcomes has been reported for the Comprehensive Stuttering Program (CSP). However, little is known about longer term outcomes of the CSP. Yearly follow-up measures were obtained from 18 participants for 5 consecutive years. At 5-year follow-up, participants were maintaining clinically and statistically significant reductions in stuttering and increases in rates of speech relative to pre-treatment measures. Standardized effect sizes were large. There were no significant differences among the immediate post-treatment and five follow-up measures, indicating that speech gains achieved by the end of the treatment program were stable over the 5-year follow-up period. Insufficient return rates for self-report data for the third to fifth follow-up measurement occasions prohibited analyzing these data. However, non-significant differences among the immediate post-treatment and two follow-up measures indicated that improvements achieved by the end of treatment in speech-related confidence, and perceptions of struggle, avoidance, and expectancy to stutter were stable over the 2-year follow-up period. Significant differences among the speech-related communication attitudes scores indicated that improvements in attitudes made at the end of the treatment program were less stable. Taken together, these results provide further and longer term evidence of the effectiveness of the CSP. EDUCATIONAL
OBJECTIVES: Readers will be able to: (1) describe the main components of the Comprehensive Stuttering Program (2) describe a methodology for determining clinically meaningful maintenance of stuttering reductions, and (3) describe the durability and stability of improvements in speech and self-report measures across time. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609333     DOI: 10.1016/j.jfludis.2010.04.002

Source DB:  PubMed          Journal:  J Fluency Disord        ISSN: 0094-730X            Impact factor:   2.538


  5 in total

1.  Efficacy of the Modifying Phonation Intervals (MPI) Stuttering Treatment Program With Adults Who Stutter.

Authors:  Roger J Ingham; Janis C Ingham; Anne K Bothe; Yuedong Wang; Martin Kilgo
Journal:  Am J Speech Lang Pathol       Date:  2015-05       Impact factor: 2.408

2.  The Pathogenesis, Assessment and Treatment of Speech Fluency Disorders.

Authors:  Katrin Neumann; Harald A Euler; Hans-Georg Bosshardt; Susanne Cook; Patricia Sandrieser; Martin Sommer
Journal:  Dtsch Arztebl Int       Date:  2017-06-05       Impact factor: 5.594

Review 3.  Speech and Anxiety Management With Persistent Stuttering: Current Status and Essential Research.

Authors:  Robyn Lowe; Ross Menzies; Mark Onslow; Ann Packman; Sue O'Brian
Journal:  J Speech Lang Hear Res       Date:  2021-01-05       Impact factor: 2.297

Review 4.  The state of the art in non-pharmacological interventions for developmental stuttering. Part 1: a systematic review of effectiveness.

Authors:  Susan Baxter; Maxine Johnson; Lindsay Blank; Anna Cantrell; Shelagh Brumfitt; Pam Enderby; Elizabeth Goyder
Journal:  Int J Lang Commun Disord       Date:  2015-06-30       Impact factor: 3.020

Review 5.  Management options for pediatric patients who stutter: current challenges and future directions.

Authors:  Michelle A Donaghy; Kylie A Smith
Journal:  Pediatric Health Med Ther       Date:  2016-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.